Clinical Potential of Emerging New Agents in Hepatitis B

ISSN： 0012-6667

Source： Drugs, Vol.60, Iss.4, 2000-10, pp. : 701-710

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Agents in clinical development for the treatment of chronic hepatitis B

By Raney Anneke K Hamatake Robert K Hong Zhi

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1281-1295

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for hepatitis B

By Zoulim Fabien

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 199-217

Informa Healthcare

Access to resources Recommend Favorite

Emerging treatments in chronic hepatitis B

By Hadziyannis Stephanos J Papatheodoridis George V

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 2, 2004-11 ,pp. : 207-221

Informa Healthcare

Access to resources Recommend Favorite

Exploiting New Potential Targets for Anti-Hepatitis B Virus Drugs

Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 3, 2003-09 ,pp. : 241-246

Bentham Science Publishers

Access to resources Recommend Favorite

The clinical virology of hepatitis B

By Revill Peter Locarnini Stephen

Future Virology, Vol. 1, Iss. 3, 2006-05 ,pp. : 349-360

Future Medicine

Access to resources Recommend Favorite